Pharmaceutical Technology on MSN
MSD secures $700m for broad-cancer ADC asset
MSD’s deal comes in the form of $700m in funding secured from Blackstone Life Sciences. The tranche will go towards the ...
Merck & Co. began Tuesday with back-to-back deals, revealing separate agreements to pay $150 million upfront for full control of an early-phase asset and pocket $700 million to support an expansive ...
The deal hands Blackstone a piece of the potential future sales of an antibody-drug conjugate that could soon challenge marketed medicines from AstraZeneca and Gilead.
When Daiichi Sankyo decided to move to its new U.S. headquarters in Basking Ridge, bringing more than 700 jobs in the process, it sought two things: to consolidate its offices in Parsippany and Edison ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback